Extended Use of Hypothermia in Elderly Patients with Malignant Cerebral Edema as an Alternative to Hemicraniectomy
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background and Purpose The use of decompressive hemicraniectomy (DHC) for the treatment of malignant cerebral edema can decrease mortality rates. However, this benefit is not sufficient to justify its use in elderly patients. We investigated the effects of therapeutic hypothermia (TH) on safety, feasibility, and functional outcomes in elderly patients with malignant middle cerebral artery (MCA) infarcts. Methods Elderly patients 60 years of age and older with infarcts affecting more than two-thirds of the MCA territory were included. Patients who could not receive DHC were treated with TH. Hypothermia was started within 72 hours of symptom onset and was maintained for a minimum of 72 hours with a target temperature of 33°C. Modified Rankin Scale (mRS) scores at 3 months following treatment and complications of TH were used as functional outcomes. Results Eleven patients with a median age of 76 years and a median National Institutes of Health Stroke Scale score of 18 were treated with TH. The median time from symptom onset to initiation of TH was 30.3±23.0 hours and TH was maintained for a median of 76.7±57.1 hours. Shivering (100%) and electrolyte imbalance (82%) were frequent complications. Two patients died (18%). The mean mRS score 3 months following treatment was 4.9±0.8. Conclusions Our results suggest that extended use of hypothermia is safe and feasible for elderly patients with large hemispheric infarctions. Hypothermia may be considered as a therapeutic alternative to DHC in elderly individuals. Further studies are required to validate our findings.
Abstract
Background and Purpose The use of decompressive hemicraniectomy (DHC) for the treatment of malignant cerebral edema can decrease mortality rates. However, this benefit is not sufficient to justify its use in elderly patients. We investigated the effects of therapeutic hypothermia (TH) on safety, feasibility, and functional outcomes in elderly patients with malignant middle cerebral artery (MCA) infarcts. Methods Elderly patients 60 years of age and older with infarcts affecting more than two-thirds of the MCA territory were included. Patients who could not receive DHC were treated with TH. Hypothermia was started within 72 hours of symptom onset and was maintained for a minimum of 72 hours with a target temperature of 33°C. Modified Rankin Scale (mRS) scores at 3 months following treatment and complications of TH were used as functional outcomes. Results Eleven patients with a median age of 76 years and a median National Institutes of Health Stroke Scale score of 18 were treated with TH. The median time from symptom onset to initiation of TH was 30.3±23.0 hours and TH was maintained for a median of 76.7±57.1 hours. Shivering (100%) and electrolyte imbalance (82%) were frequent complications. Two patients died (18%). The mean mRS score 3 months following treatment was 4.9±0.8. Conclusions Our results suggest that extended use of hypothermia is safe and feasible for elderly patients with large hemispheric infarctions. Hypothermia may be considered as a therapeutic alternative to DHC in elderly individuals. Further studies are required to validate our findings.
참고문헌 (28)
- Hacke W, "‘Malignant’ middle cerebral artery territory infarction : clinical course and prognostic signs", Arch Neurol, 53, pp.309~315 (1996)
- Heinsius T, "Large infarcts in the middle cerebral artery territory. Etiology and outcome patterns", Neurology, 50, pp.341~350 (1998)
- Frank JI, "Large hemispheric infarction, deterioration, and intracranial pressure", Neurology, 45, pp.1286~1290 (1995)
- Hofmeijer J, "Treatment of space-occupying cerebral infarction", Crit Care Med, 31, pp.617~625 (2003)
- Bardutzky J, "Antiedema therapy in ischemic stroke", Stroke, 38, pp.3084~3094 (2007)
- Juttler E, "Clinical review : therapy for refractory intracranial hypertension in ischaemic stroke", Crit Care, 11, pp.231~ (2007)
- Vahedi K, "Early decompressive surgery in malignant infarction of the middle cerebral artery : a pooled analysis of three randomised controlled trials", Lancet Neurol, 6, pp.215~222 (2007)
- ): a multicentre, open, randomised trial, "Lancet Neurol", 2009, 326~333
- Vahedi K, "Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial)", Stroke, 38, pp.2506~2517 (2007)
- Juttler E, "Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial", Stroke, 38, pp.2518~2525 (2007)
- Uhl E, "Outcome and prognostic factors of hemicraniectomy for space occupying cerebral infarction", J Neurol Neurosurg Psychiatry, 75, pp.270~274 (2004)
- Holtkamp M, "Hemicraniectomy in elderly patients with space occupying media infarction : improved survival but poor functional outcome", J Neurology Neurosurg Psychiatry, 70, pp.226~228 (2001)
- Juttler E, "Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke", N Engl J Med, 370, pp.1091~1100 (2014)
- Den Hertog HM, "Cooling therapy for acute stroke", Cochrane Database Syst Rev, pp.CD001247~ (2009)
- Krieger DW, "Cooling for acute ischemic brain damage(cool aid) : an open pilot study of induced hypothermia in acute ischemic stroke", Stroke, 32, pp.1847~1854 (2001)
- De Georgia MA, "Cooling for Acute Ischemic Brain Damage(COOL AID) : a feasibility trial of endovascular cooling", Neurology, 63, pp.312~317 (2004)
- Hemmen TM, "Multimodal neuroprotective therapy with induced hypothermia after ischemic stroke", Stroke, 40(Suppl), pp.S126~S128 (2009)
- Polderman KH, "Mechanisms of action, physiological effects, and complications of hypothermia", Crit Care Med, 37(Suppl), pp.S186~S202 (2009)
- Linares G, "Hypothermia for the treatment of ischemic and hemorrhagic stroke", Crit Care Med, 37(Suppl), pp.S243~S249 (2009)
- Guluma KZ, "Effect of endovascular hypothermia on acute ischemic edema : morphometric analysis of the ICTuS trial", Neurocrit Care, 8, pp.42~47 (2008)
- Dellinger RP, "Surviving Sepsis Campaigr Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock", Intensive Care Med, 39, pp.165~228 (2012)
- Hacke W, "Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)", JAMA, 274, pp.1017~1025 (1995)
- Hacke W, "Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators", Lancet, 352, pp.1245~1251 (1998)
- Ropper AH, "Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass", N Engl J Med, 314, pp.953~958 (1986)
- Clifton GL, "Lack of effect of induction of hypothermia after acute brain injury", N Engl J Med, 344, pp.556~563 (2001)
- Choi HA, "Prevention of shivering during therapeutic temperature modulation : the Columbia anti-shivering protocol", Neurocrit Care, 14, pp.389~394 (2011)
- Georgiadis D, "Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke", Stroke, 33, pp.1584~1588 (2002)
- Hemmen TM, "Intravenous thrombolysis plus hypothermia for acute treatment of ischemic stroke(ICTuS-L) : final results", Stroke, 41, pp.2265~2270 (2010)